US FDA’s Cavazzoni Says Retaining Virtual Meetings Could Improve Communications Going Forward
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.
You may also be interested in...
Despite acknowledging that fully in-person meetings overall are better, survey respondents said they still want the flexibility that virtual attendance offers.
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.
Patrizia Cavazzoni, FDA Center for Drug Evaluation and Research director, knows she has ‘huge shoes’ to fill. Convincing the CDER staff that she is capable of doing so is job one.